Inhibition of RANKL is critical for accurate assessment of anti-drug antibody incidence to denosumab in clinical studies. - Miller MJ; Kroenke MA; Barger T; Manning MS; Sohn W; Graham K; Mytych DT; Gupta S (Journal of immunological methods, 2025)